Persistent lymphocytic leukemia (CLL) is often a lymphoid malignancy characterised by the proliferation and accumulation of mature CD5+ B cells within the blood, bone marrow and lymphoid tissues. The diagnosis of CLL calls for the existence of ≥five x109/L mono - clonal B cells of regular phenoty